Related Experiment Video

Updated: Sep 9, 2025

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
05:16

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

Published on: July 25, 2025

285

RNA Therapeutics for In Vivo CAR-Macrophage: Advancing Cardiac Immunotherapy

Soumaya Ben-Aicha1, Talia A Shmool2, Costanza Emanueli1

  • 1National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.B.-A., C.E.).

Circulation Research
|August 28, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Editorialsfibrosisheart diseasesimmunotherapymacrophagesmyocardial infarctionreceptors, chimeric antigen

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

791
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.5K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659